Results 191 to 200 of about 76,053 (241)

Pembrolizumab-Induced Colitis With Concurrent Capecitabine in Triple-Negative Breast Carcinoma: A Case Report. [PDF]

Cureus
Kafka W, Frandah W, Diks J.
europepmc   +1 more source

A case of descending colon cancer achieving a complete response with preoperative capecitabine plus oxaliplatin therapy following colorectal stenting. [PDF]

J Surg Case Rep
Mitsuhara C, Nishihara M, Ozawa N, Asano S.   +3 more
europepmc   +1 more source

DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancer. [PDF]

ESMO Gastrointest Oncol
Janjigian YY, Smyth E, Shen L, Lee J, Hoff PM, Lonardi S, Barrios D, Kobayashi K, Okuda Y, Kamio T, Shitara K.   +10 more
europepmc   +1 more source

Alpha-Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC): A Case Report. [PDF]

Cancer Rep (Hoboken)
Zhong K, Wu X, Lin X, Xie M, Deng M, Tao Q, Qin W, Peng S.   +7 more
europepmc   +1 more source

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study. [PDF]

Cardiooncology
Shanmuganathan JWD, Kragholm K, Yonis H, Schou M, Torp-Pedersen C, Poulsen LØ, Pareek M, Gislason G, Køber L, Nielsen D, El-Galaly TC, Søgaard P, Mamas MA, Freeman P.   +13 more
europepmc   +1 more source

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update). [PDF]

Curr Oncol
Kumar A, Jerzak KJ, Gelmon KA, Boileau JF, Bouganim N, Brezden-Masley C, Cao JQ, Cescon DW, Chia S, Edwards S, Joy AA, Laing K, LeVasseur N, Sehdev S, Simmons C, Webster M, Manna M, On Behalf Of Patient Advocacy Breast Cancer Canada.   +17 more
europepmc   +1 more source

Adjuvant tislelizumab, lenvatinib, and capecitabine for resected biliary tract cancer: a prospective phase II trial. [PDF]

BMC Med
Feng Y, Zhang N, Zhao YM, Pan Q, Mao AR, Zhu WP, Zhang T, Wang L.   +7 more
europepmc   +1 more source

Intratumoral microbiota-derived S1P sensitizes the combination therapy of capecitabine and PD-1 inhibitors. [PDF]

iScience
Dai CS, Qi TT, Shang HL, Xie RH, Liu H, Liu ZM, Cui YM, Zhang YH.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Capecitabine

Drugs, 2012
Antona J Wagstaff
exaly   +3 more sources